Tf-conjugated solid lipid nanoparticles were designed for selectively targeting etoposide to human non-small cell lung cancer resulting in sustained drug release, improved plasma concentrations and accumulation of etoposide in targeted lung tissues.
No takes yet. Share an insight, caveat, or question.
Pooja et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: